Clinical Trial Update: A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase II randomized trial evaluating three regimens of GX301 vaccination in men with castration-resistant prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• GX301

Snippet

Sponsor: Laboratoires Leurquin Mediolanum | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED